Highlight
– Pretreatment screening with QuantiFERON-TB (QFT) Gold alone significantly reduced TB infection diagnoses and preventive therapy prescriptions compared to dual testing.
– Incident TB during biologic therapy remained low (0.8%), with most cases occurring within the first two years of treatment.
– Routine periodic TB retesting after a negative baseline screen appears unnecessary in the absence of new exposures.
I’m impressed, I have to say. Really rarely do I encounter a blog that’s both educative and entertaining, and let me tell you, you could have hit the nail on the head. Your thought is outstanding; the difficulty is something that not sufficient individuals are speaking intelligently about. I’m very completely happy that I stumbled across this in my search for something referring to this.